Targeting tumor-specific growth promoting pathways is important for successful cancer therapy, and the CXCL12/CXCR4 signaling axis is involved in tumor progression and migration in multiple tumor types [12, 39, 40]. This evidence concerns the gene CXCL12 and neoplasm.